Literature DB >> 3379725

Effect of repeated whole blood donations on serum immunoreactive erythropoietin levels in autologous donors.

T S Kickler1, J L Spivak.   

Abstract

The effect of repeated phlebotomy on serum immunoreactive erythropoietin levels was studied prospectively in 69 autologous blood donors. At the time of the initial phlebotomy, 11 men (33%) and two women (6%) were anemic; during the course of blood donations, anemia (defined as a hematocrit less than 0.41 for men and less than 0.36 for women) developed in an additional 17 men (71%) and 14 women (45%). Although there was an increase in the level of serum immunoreactive erythropoietin with successive phlebotomies, the increase was not substantially out of the normal range. The lack of an erythropoietic response to repeated phlebotomies in association with the small increment in the serum erythropoietin level was not due to iron deficiency, since the level of red-cell free protoporphyrin did not increase in these patients. We conclude that within the hematocrit range permissible for autologous blood donation, the degree of anemia experienced is insufficient to initiate an adequate increase in erythropoietin production; as a consequence, mild anemia develops in a majority of donors, and the volume of blood donated is inadequate to meet their operative needs.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3379725

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  9 in total

Review 1.  Blood management and patient specific transfusion options in total joint replacement surgery.

Authors:  J J Callaghan; A I Spitzer
Journal:  Iowa Orthop J       Date:  2000

2.  Mononuclear cells from a rare blood donor, after freezing under good manufacturing practice conditions, generate red blood cells that recapitulate the rare blood phenotype.

Authors:  Francesca Masiello; Valentina Tirelli; Massimo Sanchez; Emile van den Akker; Girelli Gabriella; Maurizio Marconi; Maria Antonietta Villa; Paolo Rebulla; Ghazala Hashmi; Carolyn Whitsett; Anna Rita Migliaccio
Journal:  Transfusion       Date:  2013-09-04       Impact factor: 3.157

3.  Autologous blood collection in anemic patients using low-dose erythropoietin therapy.

Authors:  L S Mott; J Bechinski; M J Jones
Journal:  J Natl Med Assoc       Date:  1997-06       Impact factor: 1.798

4.  Erythropoietin levels in patients depositing autologous blood in short intervals.

Authors:  A Lorentz; K U Eckardt; P M Osswald; J R Duchow
Journal:  Ann Hematol       Date:  1992-06       Impact factor: 3.673

Review 5.  Erythropoietin: from bench to bedside.

Authors:  J L Spivak
Journal:  Trans Am Clin Climatol Assoc       Date:  1991

Review 6.  Pharmacological approaches to reduce perioperative transfusion requirements in the aged.

Authors:  T Tasaki; H Ohto; R Motoki
Journal:  Drugs Aging       Date:  1995-02       Impact factor: 3.923

Review 7.  Controversies in selection of epoetin dosages. Issues and answers.

Authors:  P Zachée
Journal:  Drugs       Date:  1995-04       Impact factor: 9.546

8.  Possibility of enhanced risk of retinal neovascularization in repeated blood donors: blood donation and retinal alteration.

Authors:  Reza Rastmanesh
Journal:  Int J Gen Med       Date:  2011-09-06

9.  Increased preoperative collection of autologous blood with recombinant human erythropoietin therapy in tertiary care hospitals of Jammu.

Authors:  Kumkum Sharma; Sumit B Sharma; Imran A Pukhta; Amit B Sharma; Abdul Q Salaria
Journal:  Asian J Transfus Sci       Date:  2013-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.